About
Unveil a fresh opportunity with Erykine Erythropoietin Alfa Injection 10000IU-your last chance to reserve a celebrated solution for anemia management. Delivered in an exquisite pre-filled syringe, this crackerjack therapy features recombinant human erythropoietin alfa to enhance patient outcomes. With a potent strength of 10000 IU per 1 ml, it is expertly designed for intravenous or subcutaneous administration. This prescription-only injection is safeguarded by robust storage measures and protected packaging, ensuring reliability and efficacy. Offered by a leading exporter and supplier from India, Erykine delivers certified quality and assurance for healthcare professionals.
Advanced Application & Commercial Versatility
Erykine Erythropoietin Alfa Injection 10000IU is tailored for patients with anemia due to chronic kidney disease or cancer chemotherapy. Its application surface extends to hospital and clinic settings as well as commercial pharmaceutical supply chains. With a celebrated pre-filled syringe, it supports efficient handling, safe administration, and optimized therapeutic results-ideal for medical professionals seeking reliability. Extra features include strict storage requirements and robust packaging, making it suitable for widespread clinical and commercial use.
Main Domestic & Export Market Details
Erykine Erythropoietin Alfa Injection 10000IU is primarily distributed in major domestic markets across India and features instant product availability for swift order completion. The list price can be confirmed during inquiry, ensuring transparency for bulk buyers. Internationally, this product serves a thriving export market, reaching regions that rely on advanced anemia therapies. Payment terms and logistics are designed for seamless transaction processing, supporting regular global and domestic demand.
FAQ's of Erykine Erythropoietin Alfa Injection 10000IU:
Q: How is Erykine Erythropoietin Alfa Injection 10000IU administered?
A: This injection can be administered either intravenously (IV) or subcutaneously, as directed by a healthcare professional.
Q: What conditions does Erykine Erythropoietin Alfa Injection treat?
A: It is indicated for the treatment of anemia resulting from chronic kidney disease or cancer chemotherapy.
Q: When should Erykine be stored, and how?
A: Erykine should be stored between 2C and 8C and protected from light to preserve its efficacy throughout its 24-month shelf life.
Q: Where can Erykine Erythropoietin Alfa Injection be exported?
A: This product is supplied domestically across India and exported to major international pharmaceutical markets seeking advanced anemia therapies.
Q: What is the process for ordering Erykine as an exporter or supplier?
A: Order completion involves contacting the supplier for list price, confirming payment terms, and arranging shipment according to domestic or export requirements.
Q: How does Erykine benefit anemia patients?
A: Erykine boosts red blood cell production, helping alleviate anemia symptoms and improving overall patient energy and well-being.